FORUM 9
Organised by the European CanCer Organisation (ECCO), the European Federation of Pharmaceutical Industries & Associations (EFPIA) and the European Cancer Patients Coalition (ECPC)
Tackling cancer will be an essential element in pursuing the Sustainable Development Goal of reducing mortality from NCDs in Europe. Rising demand for cancer care comes alongside new ways to treat and care for cancer patients – in the context of healthcare budgets that are still constrained. A better understanding of the value of interventions is therefore essential to addressing these challenges. This has implications for access to medicines, but also for cancer care more broadly.
This session will feature updates on important recent initiatives amongst the cancer community, including:
Discussion will then examine different aspects of value, including:
Input from
YOLANDE LIEVENS, Immediate Past President of ESTRO; project chair ECCO
KEN MASTRIS, Board member, ECPC
LYDIA MAKAROFF, Director, ECPC
VINCENT CLAY, Senior Manager, EU Government Affairs, Pfizer
ALEXANDER ROEDIGER, Chair, EFPIA Oncology Platform; Policy Lead Oncology - Europe, Middle East, Africa & Canada (MSD)
Moderation
TAMSIN ROSE, Senior Fellow, Friends of Europe